InvestorsHub Logo
Post# of 1030
Next 10
Followers 3
Posts 391
Boards Moderated 0
Alias Born 07/23/2017

Re: None

Monday, 02/26/2018 9:41:18 AM

Monday, February 26, 2018 9:41:18 AM

Post# of 1030
2/26: DURECT Announces Patient Dosing in Phase 2a Trial of DUR-928 in Primary Sclerosing Cholangitis (PSC) (Newswire)

I read tea leaves. Keeping my teacup full.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DRRX News